| Aug 7 |
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
|
| Aug 7 |
ACADIA Pharma cut at Morgan Stanley on Daybue miss
|
| Aug 7 |
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
|
| Aug 7 |
Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues
|
| Aug 7 |
ACADIA Pharmaceuticals Inc. (ACAD) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
ACADIA Pharmaceuticals Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 6 |
Acadia Pharmaceuticals (ACAD) Beats Q2 Earnings and Revenue Estimates
|
| Aug 6 |
Acadia: Q2 Earnings Snapshot
|
| Aug 6 |
Acadia Pharma GAAP EPS of $0.20 beats by $0.03, revenue of $241.96M beats by $6.3M
|
| Aug 6 |
Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
|
